WSJ: Pfizer now expects to ship half the doses it had originally planned, from 100 million doses down to 50 million, after finding raw materials in early production didn’t meet its standards.https://t.co/82Malmr24u— Michael Del Moro (@MikeDelMoro) December 3, 2020
WSJ: Pfizer now expects to ship half the doses it had originally planned, from 100 million doses down to 50 million, after finding raw materials in early production didn’t meet its standards.https://t.co/82Malmr24u